Gwendolyn A.(gwen) Fyfe
Pharmaceuticals
Molecular Partners AG
Germany
Biography
Gwendolyn A.(Gwen) Fyfe, M.D. is Member of Board of the Directors of Molecular Partners Ltd since May 11, 2017. She has more than 20 years of drug development experience in oncology. She held various positions at Genentech from 1997-2009, including vice president, oncology development, playing an important role in the development of Genentech's approved oncology agents. In recent years, she has consulted for venture capital firms and for a variety of biotechnology companies. A recognized expert in the broader oncology community, Dr. Fyfe has been an invited member of Institute of Medicine panels, National Cancer Institute working groups and grant committees, and oversight committees of the American Society of Clinical Oncology (ASCO).
Research Interest
Pharmaceuticals
